PHR (Phreesia, Inc.) Stock Analysis - Hedge Fund Holdings
Phreesia, Inc. (PHR) is a publicly traded Healthcare sector company. As of May 21, 2026, PHR trades at $8.85 with a market cap of $560.91M and a P/E ratio of 219.88. PHR moved -3.65% today. Year to date, PHR is -48.31%; over the trailing twelve months it is -65.28%. Its 52-week range spans $7.77 to $32.76. Analyst consensus is buy with an average price target of $14.43. Rallies surfaces PHR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns PHR stock?
Hedge funds tracked by Rallies that own PHR include Panagora Asset, Centerbook Partners, Polen Capital, and Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Phreesia, Inc..
PHR Key Metrics
Key financial metrics for PHR
Metric
Value
Price
$8.85
Market Cap
$560.91M
P/E Ratio
219.88
EPS
$0.04
Dividend Yield
0.00%
52-Week High
$32.76
52-Week Low
$7.77
Volume
1.62M
Avg Volume
0
Revenue (TTM)
$480.59M
Net Income
$2.31M
Gross Margin
0.00%
Top Hedge Funds Holding PHR
Panagora Asset holds 395.54K shares of PHR, changed +29.66% as of Mar 31, 2026.
Centerbook Partners holds 32.96K shares of PHR, changed -31.79% as of Sep 30, 2024.
Polen Capital holds 17.36K shares of PHR, changed +0.00% as of Jun 30, 2025.
Bridgewater Associates holds 12.80K shares of PHR, changed -82.27% as of Dec 31, 2025.
Hedge funds tracked by Rallies that own PHR include Panagora Asset, Centerbook Partners, Polen Capital, and Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Phreesia, Inc..
Does Rallies show 13F holders for PHR?
Yes. Rallies tracks hedge fund and 13F ownership data for PHR, including fund names, share counts, latest tracked quarter, and position changes when available.
Is PHR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PHR. It does not provide personalized investment advice.